Received Jul 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015108 | — |
No additional AE; HCP reported that VARIVAX and PROQUAD were administered to multiple patients on multiple dates after being improperly stored. This case pertains to one patient who received improperly stored VARIVAX on 06/10/2025; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 10-JUN-2025, the patient was vaccinated with an improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (lot #Y015108, expiration date: 06-SEP-2026) at a dose of 0.5 mL (route of administration not reported ) which was reconstituted with sterile diluent (MERCK STERILE DILUENT), at a dose of 0.5 mL (lot # and expiration date, route of administration were not reported) for prophylaxis following a temperature excursion of 6.3F for 0 hours 16 minutes 0 seconds. No additional adverse event was reported.
Sterile diluent